phosphoserine has been researched along with Malignant Melanoma in 5 studies
Phosphoserine: The phosphoric acid ester of serine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haryuni, RD | 1 |
Watabe, S | 1 |
Yamaguchi, A | 1 |
Fukushi, Y | 1 |
Tanaka, T | 1 |
Kawasaki, Y | 1 |
Zhou, Y | 1 |
Yokoyama, S | 1 |
Sakurai, H | 1 |
Galan, JA | 1 |
Geraghty, KM | 1 |
Lavoie, G | 1 |
Kanshin, E | 1 |
Tcherkezian, J | 1 |
Calabrese, V | 1 |
Jeschke, GR | 1 |
Turk, BE | 1 |
Ballif, BA | 1 |
Blenis, J | 1 |
Thibault, P | 1 |
Roux, PP | 1 |
de Polo, A | 1 |
Luo, Z | 1 |
Gerarduzzi, C | 1 |
Chen, X | 1 |
Little, JB | 1 |
Yuan, ZM | 1 |
McNulty, SE | 1 |
del Rosario, R | 1 |
Cen, D | 1 |
Meyskens, FL | 1 |
Yang, S | 1 |
Barlati, S | 1 |
De Petro, G | 1 |
Bona, C | 1 |
Paracini, F | 1 |
Tonelli, M | 1 |
5 other studies available for phosphoserine and Malignant Melanoma
Article | Year |
---|---|
Negative feedback regulation of ErbB4 tyrosine kinase activity by ERK-mediated non-canonical phosphorylation.
Topics: Amino Acid Sequence; Extracellular Signal-Regulated MAP Kinases; Feedback, Physiological; HEK293 Cel | 2019 |
Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3.
Topics: 14-3-3 Proteins; Amino Acid Motifs; Amino Acid Sequence; Apoptosis Regulatory Proteins; Cell Line; C | 2014 |
AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.
Topics: Axl Receptor Tyrosine Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cisplatin; Cyclin | 2017 |
Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies.
Topics: Apoptosis; Biopsy; Cell Nucleus; Cytoplasm; Humans; I-kappa B Proteins; Immunohistochemistry; Melano | 2004 |
Phosphorylation of human plasminogen activators and plasminogen.
Topics: Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Humans; Immunoblotting; Melanoma; Phos | 1995 |